|
FAM190B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.396860E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.736200E-02 |
| Normal-vs-Stage2 |
3.395600E-01 |
| Normal-vs-Stage3 |
5.179200E-04 |
| Normal-vs-Stage4 |
1.59368999999021E-05 |
| Stage1-vs-Stage2 |
9.011200E-01 |
| Stage1-vs-Stage3 |
2.483900E-02 |
| Stage1-vs-Stage4 |
8.837500E-04 |
| Stage2-vs-Stage3 |
3.044200E-01 |
| Stage2-vs-Stage4 |
1.198790E-01 |
| Stage3-vs-Stage4 |
3.720000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.158100E-03 |
| Normal-vs-AfricanAmerican |
2.05679999999431E-05 |
| Normal-vs-Asian |
6.700200E-01 |
| Caucasian-vs-AfricanAmerican |
1.112060E-02 |
| Caucasian-vs-Asian |
8.191200E-01 |
| AfricanAmerican-vs-Asian |
2.160000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.641100E-04 |
| Normal-vs-Female |
3.118000E-02 |
| Male-vs-Female |
3.016600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.397180E-01 |
| Normal-vs-Age(41-60Yrs) |
8.663700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.381300E-04 |
| Normal-vs-Age(81-100Yrs) |
4.555300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.512000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.962000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.184400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.920100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.630300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.712400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.329400E-01 |
| Normal-vs-Grade 2 |
3.581000E-01 |
| Normal-vs-Grade 3 |
1.99723999999568E-05 |
| Normal-vs-Grade 4 |
3.785700000003E-05 |
| Grade 1-vs-Grade 2 |
2.052800E-01 |
| Grade 1-vs-Grade 3 |
4.222700E-04 |
| Grade 1-vs-Grade 4 |
7.196700E-04 |
| Grade 2-vs-Grade 3 |
6.967800E-04 |
| Grade 2-vs-Grade 4 |
1.058190E-03 |
| Grade 3-vs-Grade 4 |
4.679400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.789800E-01 |
| Normal-vs-ccB subtype |
2.678600E-03 |
| ccA subtype-vs-ccB subtype |
1.516220E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.240200E-02 |
| Normal-vs-N1 |
6.244200E-02 |
| N0-vs-N1 |
4.575800E-01 |
|
|
